Elsevier

Hepatology

Volume 21, Issue 3, March 1995, Pages 760-766
Hepatology

Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers

https://doi.org/10.1016/0270-9139(95)90530-8Get rights and content

Abstract

Transforming growth factor-Beta 1 (TGF-β1) is an important mediator of control of liver cell proliferation and replication. The aim of the current study was to compare TGF-β1 gene expression, protein synthesis, and cell membrane receptors in normal liver, cirrhotic nodules, and neoplastic human livers. Five surgical resections for metastasis in an otherwise normal liver and 25 resections for hepatocellular carcinoma with cirrhosis were included in this study. Messenger RNA (mRNA) and TGF-β1 protein were detected on serial tissue sections of normal, cirrhotic, and tumoral livers using in situ hybridization and immunohistochemistry. TGF-β1 type II receptors were detected on tissue sections using immunohistochemistry. In normal livers, TGF-β1 mRNA and protein were not significantly expressed. In cirrhotic nodules, a few sinusoidal cells and mesenchymal cells of fibrous septa displayed TGF-β1 mRNA. By immunohistochemistry, protein was detected in the extracellular matrix along the fibrous septa. Hepatocytes from normal and cirrhotic livers did not express TGF-β1. In contrast, the cytoplasm of hepatocytes in neoplastic nodules showed intense staining for TGF-β1 mRNA and protein. Although TGF-β1 receptor II was expressed on the plasma membrane of normal liver cells, tumoral hepatocytes no longer displayed membrane labeling but rather diffuse intracytoplasmic staining with perinuclear accumulation. This study suggests that the escape of tumoral hepatocytes from control of cell proliferation by TGF-β1, despite its overexpression by these cells, might be related to a defect in TGF-β1 receptor II processing on the liver cell membrane.

References (45)

  • FA Oberhammer et al.

    Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor /31

  • SB Jakowlew et al.

    Transforming growth factor /3 isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF Beta

    Cell Regul

    (1991)
  • WE Russel et al.

    Type /3 transforming growth factor reversibility inhibits the early proliferative response to partial hepatectomy in the rat

  • M Bachem et al.

    Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells

    J Clin Invest

    (1992)
  • SL Friedman et al.

    Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium: direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors

    J Clin Invest

    (1989)
  • BI Carr et al.

    Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type B transforming growth factor

    Cancer Res

    (1986)
  • GH Thoresen et al.

    Inhibition of hepatocyte DNA synthesis by transforming growth factor /31 and cyclic AMP: effect immediately before the G1/S border

    Cancer Res

    (1992)
  • J Massague

    The transforming growth factor beta family

    Annu Rev Cell Biol

    (1990)
  • JA Pietenpol et al.

    Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming factor growth factor /31 and by the retinoblastoma gene product

  • C Liu et al.

    Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture

    Cancer Res

    (1988)
  • BI Carr et al.

    TGF β gene transcription in normal and neoplastic liver growth

    J Cell Biochem

    (1989)
  • CH Streuli et al.

    Extracellular matrix regulates expression of the TGF-/gb1 gene

    J Cell Biol

    (1993)
  • Cited by (0)

    Supported by Grant 1.920107 from Assistance Publique-Hôpitaux de Paris and from fonds de recherche Societe Nationale française de Gastroenterologie.

    View full text